Actively Recruiting
Fluoroscopy Radiation Reduction During Sacral Neuromodulation Lead Placement
Led by Loma Linda University · Updated on 2026-03-06
44
Participants Needed
1
Research Sites
52 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Fluoroscopy is performed when placing a lead during a sacral neuromodulation procedure. During lead placement, subjects will receive either conventional or experimental fluoroscopic settings. The radiation exposure will be compared between the two groups.
CONDITIONS
Official Title
Fluoroscopy Radiation Reduction During Sacral Neuromodulation Lead Placement
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients undergoing lead implantation for sacral neuromodulation who have overactive bladder defined by urinary urgency, frequency, nocturia with or without urgency incontinence
- Age between 18 and 89 years
You will not qualify if you...
- Neurogenic bladder
- Body mass index (BMI) greater than 40
- Peripheral neuropathy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Loma Linda University Health
Loma Linda, California, United States, 92354
Actively Recruiting
Research Team
F
Forrest Jellison, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here